NORATA, GIUSEPPE DANILO
NORATA, GIUSEPPE DANILO
Dipartimento di Scienze Farmacologiche e Biomolecolari
Long-Term Follow-Up of Custom-Made Porous Hydroxyapatite Cranioplasties: Analysis of Infections in Adult and Pediatric Patients
2024 F.C. Mannella, F. Faedo, M. Fumagalli, G.D. Norata, I. Zaed, F. Servadei
ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity
2024 M. Svecla, L. Da Dalt, A. Moregola, J. Nour, A. Baragetti, P. Uboldi, E. Donetti, L. Arnaboldi, G. Beretta, F. Bonacina, G.D. Norata
Protocol to evaluate the impact of murine MCT1-deficient CD8+ T cells on adipogenesis
2023 C. Macchi, A. Moregola, G.D. Norata, M. Ruscica
Gonadal sex vs genetic sex in experimental atherosclerosis
2023 J. Nour, F. Bonacina, G.D. Norata
Finding balance between mature and immature neutrophils: The effects of empagliflozin in GSD-Ib
2023 F. Guerra, S. Gasperini, S. Bonanomi, V. Crescitelli, R. Pretese, L. Da Dalt, G.D. Norata, M. Balzarini, A. Biondi, A. Baragetti, F. Saettini
Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression
2023 R. Bellini, A. Moregola, J. Nour, Y. Rombouts, O. Neyrolles, P. Uboldi, F. Bonacina, G.D. Norata
The inhibition of inner mitochondrial fusion in hepatocytes reduces NAFL and improves metabolic profile during obesity by modulating bile acid conjugation
2023 L. Da Dalt, A. Moregola, M. Svecla, S. Pedretti, F. Fantini, M. Ronzio, P. Uboldi, D. Dolfini, E. Donetti, A. Baragetti, N. Mitro, L. Scorrano, G.D. Norata
Cardiac lipid metabolism, mitochondrial function and heart failure
2023 L. Da Dalt, A.G. Cabodevilla, I.J. Goldberg, G.D. Norata
Fibronectin extra domain a limits liver dysfunction and protects mice during acute inflammation
2023 V.K.P. Venu, A. Moregola, L. Da Dalt, P. Uboldi, F. Bonacina, A.F. Muro, G.D. Norata
Impact of asialoglycoprotein receptor and mannose receptor deficiency on murine plasma N-glycome profiles
2023 M. Svecla, J. Nour, M.R. Bladergroen, S. Nicolardi, T. Zhang, G. Beretta, M. Wuhrer, G.D. Norata, D. Falck
HDL particles and infection related death: when size matters
2023 L. Calabresi, G.D. Norata
Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid lowering
2023 G.D. Norata, L. Tokgözoğlu
Rhabdomyolysis or Severe Acute Hepatitis Associated with the Use of Red Yeast Rice Extracts: an Update from the Adverse Event Reporting Systems
2023 M. Banach, G.D. Norata
Neutrophil aging exacerbates high fat diet induced metabolic alterations
2023 A. Baragetti, L. Da Dalt, A. Moregola, M. Svecla, O. Terenghi, E. Mattavelli, L.N. De Gaetano, P. Uboldi, A.L. Catapano, G.D. Norata
The burden of hypercholesterolemia and ischemic heart disease in an ageing world
2023 A. Pirillo, G.D. Norata
Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans
2023 S. Hendrix, J. Kingma, R. Ottenhoff, M. Valiloo, M. Svecla, L.F. Zijlstra, V. Sachdev, K. Kovac, J.H.M. Levels, A. Jongejan, J.F. de Boer, F. Kuipers, A. Rimbert, G.D. Norata, A. Loregger, N. Zelcer
Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice
2023 M. Amor, V. Bianco, M. Buerger, M. Lechleitner, N. Vujić, A. Dobrijević, A. Akhmetshina, A. Pirchheim, B. Schwarz, A.R. Pessentheiner, F. Baumgartner, K. Rampitsch, S. Schauer, I. Klobučar, V. Degoricija, G. Pregartner, D. Kummer, M. Svecla, G. Sommer, D. Kolb, G.A. Holzapfel, G. Hoefler, S. Frank, G.D. Norata, D. Kratky
PITX2 gain-of-function mutation associated with atrial fibrillation alters mitochondrial activity in human iPSC atrial-like cardiomyocytes
2023 P. Benzoni, L. Da Dalt, N. Elia, V. Popolizio, A. Cospito, F. Giannetti, P. Dell'Era, M.S. Olesen, A. Bucchi, M. Baruscotti, G.D. Norata, A. Barbuti
Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies
2023 L. Tschiderer, L. Seekircher, R. Izzo, C. Mancusi, M.V. Manzi, D. Baldassarre, M. Amato, E. Tremoli, F. Veglia, T. Tuomainen, J. Kauhanen, A. Voutilainen, B. Iglseder, L. Lind, T. Rundek, M. Desvarieux, A. Kato, E. de Groot, G. Aşçi, E. Ok, S. Agewall, J.W.J. Beulens, C.D. Byrne, P.C. Calder, H.C. Gerstein, P. Gresele, G. Klingenschmid, M. Nagai, M.H. Olsen, G. Parraga, M.S. Safarova, N. Sattar, M. Skilton, C.D.A. Stehouwer, H. Uthoff, M.A. van Agtmael, A.A. van der Heijden, D.A. Zozulińska-Ziółkiewicz, H. Park, M. Lee, J. Bae, O. Beloqui, M.F. Landecho, M. Plichart, P. Ducimetiere, J.P. Empana, L. Bokemark, G. Bergström, C. Schmidt, S. Castelnuovo, L. Calabresi, G.D. Norata, L. Grigore, A. Catapano, D. Zhao, M. Wang, J. Liu, M.A. Ikram, M. Kavousi, M.L. Bots, M.J. Sweeting, M.W. Lorenz, P. Willeit
Neutral effect of SGLT2 inhibitors on lipoprotein metabolism: From clinical evidence to molecular mechanisms
2023 E. Osto, F. Bonacina, A. Pirillo, G.D. Norata